The sodium-glucose cotransport mechanism remains functional even during episodes of diarrhea, which is why balanced oral rehydration solutions (ORS) remain the gold standard for mild to moderate ...

Texas Tech University researchers used liquid chromatography–tandem mass spectrometry to quantify glucose transporter 1 (GLUT1) in mammalian brain cells.

In patients with type 2 diabetes, the risk for chronic kidney disease differed among users of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylurea.

For sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists, similar patterns were seen (14.5 to 24.4% and 19.5 to 28.5%, respectively). There was a decline in ...

The glucose tolerance test screens for gestational diabetes during pregnancy. Typically, your doctor or medical professional will ask you to have a glucose screening test first. Depending on the ...

Between 2021 and 2023, prescriptions of tirzepatide, semaglutide (Novo Nordisk), and sodium-glucose cotransporter 2 (SGLT2) inhibitors for people with T2D increased dramatically, while the use of ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) are associated with a significantly lower risk of dementia and Alzheimer's disease ...

For example, several studies have recently reported that glucose-lowering drugs like glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is ...

In our study in the GLP-1s [glucagon-like peptide-1s] and then the SGLTs [sodium-glucose cotransporters], we saw that on the in the long-term, they were beneficial, but it's not been sold for ...

Newer blood glucose-lowering drugs such as glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) have shown potential beneficial effects in ...

Semaglutide's benefits were consistent across subgroups, and it can be safely used with sodium-glucose co-transporter 2 inhibitors. Researchers suggest the 20% reduction in nonfatal heart attacks ...